On February 28, GLONGHUI (02192.HK) announced that for the year ended December 31, 2023 (“Fiscal Year 2023"), the board of directors expects revenue for fiscal year 2023 to increase from RMB 314 million to no less than RMB 410 million for the year ended December 31, 2022; profit attributable to owners of parent companies recorded a significant increase, increasing to no less than RMB 235 million from the profit attributable to owners of parent companies for the year ended December 31, 2022.
医脉通(02192.HK)盈喜:预计2023财年归母净利增长至不少于2.35亿元
Medical Pulse (02192.HK) Yingxi: Net profit due to mother is expected to increase to no less than 235 million yuan in fiscal year 2023
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.